159 related articles for article (PubMed ID: 8105686)
21. Two novel splicing mutations in the XPA gene in patients with group A xeroderma pigmentosum.
Satokata I; Uchiyama M; Tanaka K
Hum Mol Genet; 1995 Oct; 4(10):1993-4. PubMed ID: 8595429
[No Abstract] [Full Text] [Related]
22. A founder large deletion mutation in Xeroderma pigmentosum-Variant form in Tunisia: implication for molecular diagnosis and therapy.
Ben Rekaya M; Laroussi N; Messaoud O; Jones M; Jerbi M; Naouali C; Bouyacoub Y; Chargui M; Kefi R; Fazaa B; Boubaker MS; Boussen H; Mokni M; Abdelhak S; Zghal M; Khaled A; Yacoub-Youssef H
Biomed Res Int; 2014; 2014():256245. PubMed ID: 24877075
[TBL] [Abstract][Full Text] [Related]
23. Analysis of cells harboring a putative DNA repair gene reveals a lack of evidence for a second independent xeroderma pigmentosum group A correcting gene.
Jones CJ; Lloyd RS; Wood RD
Mutat Res; 1994 Aug; 324(4):159-64. PubMed ID: 7519740
[TBL] [Abstract][Full Text] [Related]
24. Cloning and characterization of the mouse XPAC gene.
van Oostrom CT; de Vries A; Verbeek SJ; van Kreijl CF; van Steeg H
Nucleic Acids Res; 1994 Jan; 22(1):11-4. PubMed ID: 8127648
[TBL] [Abstract][Full Text] [Related]
25. A single-site mutation in the XPAC gene alters photoproduct recognition.
McDowell ML; Nguyen T; Cleaver JE
Mutagenesis; 1993 Mar; 8(2):155-61. PubMed ID: 8464385
[TBL] [Abstract][Full Text] [Related]
26. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
[TBL] [Abstract][Full Text] [Related]
27. An XPA gene splicing mutation resulting in trace protein expression in an elderly patient with xeroderma pigmentosum group A without neurological abnormalities.
Takahashi Y; Endo Y; Kusaka-Kikushima A; Nakamaura S; Nakazawa Y; Ogi T; Uryu M; Tsuji G; Furue M; Moriwaki S
Br J Dermatol; 2017 Jul; 177(1):253-257. PubMed ID: 27603812
[TBL] [Abstract][Full Text] [Related]
28. Stable transformation of xeroderma pigmentosum group A cells with an XPA minigene restores normal DNA repair and mutagenesis of UV-treated plasmids.
Myrand SP; Topping RS; States JC
Carcinogenesis; 1996 Sep; 17(9):1909-17. PubMed ID: 8824513
[TBL] [Abstract][Full Text] [Related]
29. Siblings with xeroderma pigmentosum complementation group A with different skin cancer development: importance of sun protection at an early age.
Kondoh M; Ueda M; Nakagawa K; Ichihashi M
J Am Acad Dermatol; 1994 Dec; 31(6):993-6. PubMed ID: 7962783
[TBL] [Abstract][Full Text] [Related]
30. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
[TBL] [Abstract][Full Text] [Related]
31. Absence of DNA repair deficiency in the confirmed heterozygotes of xeroderma pigmentosum group A.
Moriwaki S; Nishigori C; Teramoto T; Tanaka T; Kore-eda S; Takebe H; Imamura S
J Invest Dermatol; 1993 Jul; 101(1):69-72. PubMed ID: 8101209
[TBL] [Abstract][Full Text] [Related]
32. Molecular studies of Japanese patients with group A xeroderma pigmentosum using polymerase chain reaction and restriction fragment length polymorphism and nonradioactive single strand conformation polymorphism analyses.
Sumitani S; Ishikawa Y; Ishikawa Y; Minami R
J Child Neurol; 1999 Mar; 14(3):168-72. PubMed ID: 10190268
[TBL] [Abstract][Full Text] [Related]
33. A case of xeroderma pigmentosum group A diagnosed with a polymerase chain reaction (PCR) technique. Usefulness of PCR in the detection of point mutation in a patient with a hereditary disease.
Kore-eda S; Tanaka T; Moriwaki S; Nishigori C; Imamura S
Arch Dermatol; 1992 Jul; 128(7):971-4. PubMed ID: 1352672
[TBL] [Abstract][Full Text] [Related]
34. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.
Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH
J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128
[TBL] [Abstract][Full Text] [Related]
35. Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease.
States JC; Myrand SP
Mutat Res; 1996 Aug; 363(3):171-7. PubMed ID: 8765158
[TBL] [Abstract][Full Text] [Related]
36. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain.
Tanaka K; Miura N; Satokata I; Miyamoto I; Yoshida MC; Satoh Y; Kondo S; Yasui A; Okayama H; Okada Y
Nature; 1990 Nov; 348(6296):73-6. PubMed ID: 2234061
[TBL] [Abstract][Full Text] [Related]
37. Chronological difference in walking impairment among Japanese group A xeroderma pigmentosum (XP-A) patients with various combinations of mutation sites.
Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K
Clin Genet; 1995 Nov; 48(5):225-31. PubMed ID: 8825598
[TBL] [Abstract][Full Text] [Related]
38. DNA-based prenatal carrier detection for group A xeroderma pigmentosum in a chorionic villus sample.
Matsumoto N; Saito N; Harada N; Tanaka K; Niikawa N
Prenat Diagn; 1995 Jul; 15(7):675-7. PubMed ID: 8532631
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of xpac protein, the gene product of the human XPAC (xeroderma pigmentosum group A complementing) gene.
Miura N; Miyamoto I; Asahina H; Satokata I; Tanaka K; Okada Y
J Biol Chem; 1991 Oct; 266(29):19786-9. PubMed ID: 1918083
[TBL] [Abstract][Full Text] [Related]
40. Effect of XPA gene mutations on UV-induced immunostaining of PCNA in fibroblasts from xeroderma pigmentosum group A patients.
Miura M; Sasaki T
Mutat Res; 1996 Sep; 364(1):51-6. PubMed ID: 8814338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
